Onego Bio Revenue and Competitors

Helsinki, FI

Location

$56M

Total Funding

Food

Industry

Estimated Revenue & Valuation

  • Onego Bio's estimated annual revenue is currently $16.3M per year.(i)
  • Onego Bio's estimated revenue per employee is $243,000
  • Onego Bio's total funding is $56M.

Employee Data

  • Onego Bio has 67 Employees.(i)
  • Onego Bio grew their employee count by 52% last year.

Onego Bio's People

NameTitleEmail/Phone
1
VP CommercialReveal Email/Phone
2
Head Product DevelopmentReveal Email/Phone
3
Head BiologyReveal Email/Phone
4
Head Brand & CommunicationsReveal Email/Phone
5
Downstream Process EngineerReveal Email/Phone
6
Marketing CoordinatorReveal Email/Phone
7
Communications SpecialistReveal Email/Phone
8
Junior Downstream Process EngineerReveal Email/Phone
9
LaboratorieassistentReveal Email/Phone
10
Bioprocess TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$126.6M37544%N/AN/A
#2
$16.3M6752%$56.3MN/A
#3
$6.9M244%$2.53MN/A
Add Company

What Is Onego Bio?

Onego Bio is a US-Finnish food-biotech company revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen®, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly efficient and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected the Winner of Fast Company’s 2023 World Changing Ideas awards and is a co-founder of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.

keywords:N/A

$56M

Total Funding

67

Number of Employees

$16.3M

Revenue (est)

52%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.3M6724%N/A
#2
$17.5M67-7%N/A
#3
$9.4M6722%N/A
#4
$10.9M6720%N/A
#5
$8.7M67-19%N/A